Literature DB >> 33104300

COVID-19: a user's guide, status of the art and an original proposal to terminate viral recurrence.

Giovanni C Actis1, Davide G Ribaldone2, Sharmila Fagoonee3, Rinaldo Pellicano4.   

Abstract

The world is now entering its 9th month of combat against a pandemic of deadly pneumonia. Started out from China in December 2019, the disease has been declared as caused by infection with a so far unknown RNA Coronavirus of the respiratory family, then named severe acute respiratory syndrome coronavirus SARS-CoV-2. In the absence of a vaccine, and with scientists still struggling for an effective therapy, COVID-19 (the SARS-dependent syndrome) carries up to now, a death toll of more than 590,000 (July 18,2020) undermining jobs and finance of contemporary society in all continents. Social distancing, the only measure hitherto shown to restrain virus spread, has been progressively loosened from May 2020 in some countries, leaving us in the fear of repeat attacks from the unchecked virus. We discuss the problem and propose to tentatively boost the antivirus cell machinery by using lab-made viral mimics to engage cell receptors.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 33104300     DOI: 10.23736/S0026-4806.20.07054-8

Source DB:  PubMed          Journal:  Minerva Med        ISSN: 0026-4806            Impact factor:   4.806


  1 in total

1.  Effect of COVID-19 Pandemic on Hepatocellular Carcinoma Diagnosis: Results from a Tertiary Care Center in North-West Italy.

Authors:  Davide Giuseppe Ribaldone; Gian Paolo Caviglia; Silvia Gaia; Emanuela Rolle; Alessandra Risso; Daniela Campion; Paola Rita Brunocilla; Giorgio Maria Saracco; Patrizia Carucci
Journal:  Curr Oncol       Date:  2022-02-24       Impact factor: 3.677

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.